1. Summary Information

 

 

Country

India

Company Name

GRINDLAYS PHARMACEUTICALS PRIVATE LIMITED

Principal Name 1

Mr. Ramkrishna Harishet Kolwankar

Status

Satisfactory

Principal Name 2

Mr. Dhanashri Ramkrishna Kolwankar

 

 

Registration #

11-037368

Street Address

Office No. 406, 407 and 408, 4th Floor, Swastik Chambers, CST Road, Chembur – 400071, Maharashtra

Established Date

04.09.1985

SIC Code

--

Telephone#

91-22-5278801/ 02/ 03

Business Style 1

Manufacture

Fax #

91-22-5974547

Business Style 2

--

Homepage

http://www.grinpharma.com

Product Name 1

Bulk Drugs 

# of employees

Not Available

Product Name 2

Intermediates

Paid up capital

Rs.5,000,000/-

Product Name 3

--

Shareholders

Directors Relatives – 100%

Banking

Bank of India

Public Limited Corp.

No

Business Period

27 Years

IPO

No

International Ins.

-

Public Enterprise

No

Rating

Ba (44)

Related Company

Relation

Country

Company Name

CEO

--

--

--

--

Note

-

 

2. Summary Financial Statement

Balance Sheet as of

31.03.2011

(Unit: Indian Rs.)

Assets

Liabilities

Current Assets

31,263,000

Current Liabilities

14,288,000

Inventories

7,764,000

Long-term Liabilities

22,591,000 

Fixed Assets

18,757,000

Other Liabilities

1,890,000

Deferred Assets

0,000

Total Liabilities

 38,769,000

Invest& other Assets

0,000

Retained Earnings

14,015,000

 

 

Net Worth

19,015,000

Total Assets

57,784,000

Total Liab. & Equity

57,784,000

 Total Assets

(Previous Year)

49,922,000

 

 

P/L Statement as of

31.03.2011

(Unit: Indian Rs.)

Sales

127,098,000

Net Profit

3,894,000

Sales(Previous yr)

118,283,000

Net Profit(Prev.yr)

3,420,000

 

MIRA INFORM REPORT

 

 

Report Date :

02.03.2012

 

IDENTIFICATION DETAILS

 

Name :

GRINDLAYS PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

Office No. 406, 407 and 408, 4th Floor, Swastik Chambers, CST Road, Chembur – 400071, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

04.09.1985

 

 

Com. Reg. No.:

11-037368

 

 

Capital Investment / Paid-up Capital :

Rs.5.000 Millions

 

 

CIN No.:

[Company Identification No.]

U99999MH1985PTC037368

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMG05658C

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturers of Bulk Drugs and Intermediates.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (44)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 76000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LOCATIONS

 

Registered Office :

Office No. 406, 407 and 408, 4th Floor, Swastik Chambers, CST Road, Chembur – 400071, Maharashtra

Tel. No.:

91-22-25278801/ 02/ 03

Fax No.:

91-22-25974547

E-Mail :

grinpharma@vsnl.net

Website :

http://www.grinpharma.com

 

 

Factory :

Plot No: 87, Panvel Industrial Co-Operative Estate Limited, Panvel, District Raigad, Navi Mumbai-410206.

Tel. No.:

91-22-56244677

Fax No.:

91-22-56244689

Area :

Owned

Location :

35 SQ, Mtrs

 

 

DIRECTORS

 

As on 30.09.2011

 

Name :

Mr. Ramkrishna Harishet Kolwankar

Designation :

Managing director

Address :

Bunglow No. 6, Zarina Park, Opposite Anushakti Bus Depot, Mankhurd (East), Mumbai – 400088, Maharashtra, India

Date of Birth/Age :

30.08.1944

Date of Appointment :

18.10.1985

DIN No.:

00293905

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U99999MH1985PTC037368

GRINDLAYS PHARMACEUTICALS PRIVATE LIMITED

Managing director

15-10-85

15-10-85

-

Active

NO

2

U24239MH2006PLC166544

GRINDLAYS BIOSCIENCES LIMITED

Director

27-12-06

27-12-06

-

Strike off

NO

3

U24110PN1982PTC026458

CHIPLUN FINE CHEMICALS PRIVATE LIMITED

Additional director

07-04-08

07-04-08

08-04-08

Dormant

NO

4

U24110MH1987PTC042146

FERICO HEALTHCARE PRIVATE LIMITED

Director

30-09-09

15-10-08

-

Active

NO

 

 

Name :

Mr. Dhanashri Ramkrishna Kolwankar

Designation :

Director

Address :

Bunglow No. 6, Zarina Park, Opposite Anushakti Bus Depot, Mankhurd (East), Mumbai – 400088, Maharashtra, India

Date of Birth/Age :

12.11.1974

Date of Appointment :

31.05.1995

DIN No.:

00294157

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U99999MH1985PTC037368

GRINDLAYS PHARMACEUTICALS PRIVATE LIMITED

Director

31-03-95

31-03-95

-

Active

NO

2

U24239MH2006PLC166544

GRINDLAYS BIOSCIENCES LIMITED

Director

27-12-06

27-12-06

-

Strike off

NO

3

U24110MH1987PTC042146

FERICO HEALTHCARE PRIVATE LIMITED

Director

30-09-09

15-10-08

-

Active

NO

 

 

Name :

Mr. Santosh Ramkrishna Kolwankar

Designation :

Additional director

Address :

Bunglow No. 6, Zarina Park, Opposite Anushakti Bus Depot, Mankhurd (East), Mumbai – 400088, Maharashtra, India

Date of Birth/Age :

16.11.2009

Date of Appointment :

16.11.2009

DIN No.:

00293852

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24110MH1987PTC042146

FERICO HEALTHCARE PRIVATE LIMITED

Director

31-03-95

31-03-95

-

Active

NO

2

U24239MH2006PLC166544

GRINDLAYS BIOSCIENCES LIMITED

Director

27-12-06

27-12-06

-

Strike off

NO

3

U24110PN1982PTC026458

CHIPLUN FINE CHEMICALS PRIVATE LIMITED

Additional director

07-04-08

07-04-08

-

Dormant

NO

4

U99999MH1985PTC037368

GRINDLAYS PHARMACEUTICALS PRIVATE LIMITED

Additional director

16-11-09

16-11-09

-

Active

NO

 

 

Name :

Mr. Arti Ramkrishna Kolwankar

Designation :

Director

Address :

Bunglow No. 6, Zarina Park, Opposite Anushakti Bus Depot, Mankhurd (East), Mumbai – 400088, Maharashtra, India

Date of Birth/Age :

23.04.1951

Date of Appointment :

01.04.1997

DIN No.:

00300218

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U99999MH1985PTC037368

GRINDLAYS PHARMACEUTICALS PRIVATE LIMITED

Director

01-04-97

01-04-97

-

Active

NO

2

U24110MH1987PTC042146

FERICO HEALTHCARE PRIVATE LIMITED

Director

25-03-99

25-03-99

15-12-08

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2011

 

Names of Shareholders

 

No. of Shares

Ramkrishna Harishsheth Kolwankar

 

242500

Arti Ramkrishna Kolwankar

 

213200

Dhanashri Ramkrishna Kolwankar

 

160000

Santosh Ramkrishna Kolwankar

 

10000

TOTAL

 

625700

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2011

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturers of Bulk Drugs and Intermediates.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

Bank of India, Chembur Branch, Chembur Naka, R C Marg, Mumbai – 400071, Maharashtra, India

 

 

Facilities :

Secured Loan

As on

31.03.2010

(Rs. in

Millions)

As on

31.03.2010

(Rs. in

Millions)

Loan against FD

0.000

0.900

Bank of India Cash Credit

7.469

4.618

Bank of India – EPC

7.402

8.637

Bank of India – Bills Discounted (FDBP)

7.233

8.936

Cars Loan Skoda BOI

0.487

0.843

Total

22.591

23.934

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Karia and Shah

Chartered Accountant

Address :

Flat No.9, 3rd Floor, Rajgir Sadan, Opposite Sion Railway Station, Sion (West), Mumbai – 400022, Maharashtra, India

Tel. No.:

91-22-24044828/ 24072650

E-Mail :

kariashah@yahoo.com

PAN.:

AAACG1836D

 

 

 

 

 

 

 

 

 

 

CAPITAL STRUCTURE

 

As on 30.09.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

1000000

Equity Shares

Rs.10/- each

Rs.10.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

625700

Equity Shares

Rs.10/- each

Rs.6.257 Millions

 

 

 

 

 

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

500000

Equity Shares

Rs.10/- each

Rs.5.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

500000

Equity Shares

Rs.10/- each

Rs.5.000 Millions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

5.000

5.000

5.000

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

14.015

10.433

7.012

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

19.015

15.433

12.012

LOAN FUNDS

 

 

 

1] Secured Loans

22.591

23.934

24.567

2] Unsecured Loans

0.000

0.000

0.300

TOTAL BORROWING

22.591

23.934

24.867

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

41.606

39.367

36.879

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

18.757

15.729

13.617

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

1.062

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

7.764

4.534

4.949

 

Sundry Debtors

14.910

20.934

16.177

 

Cash & Bank Balances

0.095

0.532

0.809

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

16.258

7.131

10.069

Total Current Assets

39.027

33.131

32.004

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

14.288

8.029

7.843

 

Other Current Liabilities

0.000

0.000

0.000

 

Provisions

1.890

2.526

0.899

Total Current Liabilities

16.178

10.555

8.742

Net Current Assets

22.849

22.576

23.262

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

41.606

39.367

36.879

 

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

127.098

118.283

111.807

 

 

Other Income

7.944

1.318

NA

 

 

TOTAL                                    

135.042

119.601

NA

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

120.421

112.733

 

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

120.421

112.733

NA

 

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

14.621

6.868

 

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

8.973

1.763

NA

 

 

 

 

 

 

PROFIT BEFORE TAX

5.648

5.105

1.947

 

 

 

 

 

Less

TAX                                                                 

1.754

1.685

NA

 

 

 

 

 

 

PROFIT AFTER TAX

3.894

3.420

NA

 

 

 

 

 

 

Earnings Per Share (Rs.)

7.17

6.84

--

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

2.88

2.86

NA

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

4.44

4.32

1.74

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

9.77

10.45

4.27

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.30

0.33

0.16

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

2.89

2.23

2.80

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.41

2.13

3.66

 

 

LOCAL AGENCY FURTHER INFORMATION

 

FINANCIAL REPORT

 

During the year the total sales achieved Rs.127.098 millions the profit for the year after tax at Rs.3.891 millions. Directors are looking ahead for the better prospects.

 

FORM 8

Corporate identity number of the company

U99999MH1985PTC037368

Name of the company

GRINDLAYS PHARMACEUTICALS PVT LTD

Address of the registered office or of the principal place of  business in India of the company

Office No. 406, 407 and 408, 4th Floor, Swastik Chambers, CST Road, Chembur – 400071, Maharashtra

Email: grinpharma@vsnl.net

This form is for

Modification of charge

Charge identification (ID) number of the charge to be modified

10129800

Type of charge

Immovable Property

Particular of charge holder

Bank of India, Chembur Branch, Chembur Naka, R C Marg, Mumbai – 400071, Maharashtra, India

Email: info@ca-adlalwani.com

Nature of instrument creating charge

1.Release Letter of Property Situated At 24,SwastikChambers,Cst Road, Chembur, Mumbai -400071, Maharashtra, India

Date of instrument Creating the charge

07.09.2011

Amount secured by the charge

Rs.37.326 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

As Stipulated By Bank From Time To Time

 

Terms of Repayment

As Stipulated By Bank From Time To Time

 

Margin

As Stipulated By Bank From Time To Time

 

Extent and Operation of the charge

First charge (present and future) total limit rs. 373.26 lacs

 

And / or as stipulated by bank from time to time

 

Others

As Stipulated by Bank From Time To Time and As Per Agreement Attached and as Per Sanction Letter of The Bank

Short particulars of the property or asset(s) charged (including complete address and location of the property)

First charge (present and future)

(1)equitable mortgage by deposit of title deeds over immovable properties, comprising land and building and other structure, fixed machinery, plant fixtures/ fittings erected or installed thereon situate at Plot No: 87, Panvel Industrial Co-Operative Estate Limited, Panvel, District Raigad, Navi Mumbai-410206. ( built up area 350 sq. mtrs )

Particulars of the present modification

By this modification limit remain same Rs.37.326 millions ,bank has released security of property situated at 24,Swastik Chambers, Cst Road, Chembur, Mumbai -71 ,other securities are continued as given by original charge as well as by modification

 

FIXED ASSETS

 

  • Office Equipment
  • Plant and Machinery
  • Computer
  • Furniture and Fixture
  • Telephone Equipment
  • Lab Equipment
  • Air Conditioner
  • Office Premises
  • Factory Building
  • Motor Car
  • Residential Premises
  • New Industrial Land
  • Water Tank
  • Electric Fitting
  • Refrigerator

 

 


·         CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.49.15

UK Pound

1

Rs.78.25

Euro

1

Rs.65.57

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

44

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.